# MiR-31 enhances porcine oocyte maturation via MAPK8/JNK-mediated cumulus expansion and cytoplasmic maturation

**Authors:** Yuyang Zhang, Weiyu Gu, Zhiwei Yao, Jie Wang, Xuan Chen, Yi Jin

PMC · DOI: 10.1093/jas/skag036 · 2026-02-16

## TL;DR

This study shows that miR-31 improves the maturation of pig oocytes by regulating the MAPK8/JNK pathway, enhancing cumulus cell expansion and oocyte quality.

## Contribution

The study identifies miR-31 as a novel regulator of porcine oocyte maturation through the MAPK8/JNK pathway.

## Key findings

- miR-31 overexpression increases cumulus cell expansion and oocyte maturation rates.
- miR-31 improves oocyte quality by enhancing mitochondrial function and redox balance.
- Inhibiting miR-31 activates the MAPK8/JNK pathway and disrupts oocyte maturation.

## Abstract

This study elucidates the molecular mechanism by which porcine ovarian cumulus cell-derived miR-31 regulates oocyte IVM through the MAPK8/JNK signaling pathway, with particular emphasis on its biological roles in cumulus cell expansion and oocyte maturation quality. The experimental design comprised four treatment groups: miR-31 mimics group, mimics negative control (NC) group, miR-31 inhibition group, and inhibition NC group. The results showed: 1) miR-31 overexpression significantly enhanced cumulus cell expansion processes, upregulating PTGS2 (P < 0.05) and PTX3 (P < 0.01) gene expression, while concurrently increasing oocyte maturation rates (P < 0.05). 2) Oocyte quality analysis revealed that miR-31 overexpression induced: elevated mitochondrial membrane potential (P < 0.05); increased ATP production (P < 0.05); reduced lipid droplet size (P < 0.05) with concurrent quantity increased (P < 0.05); improved redox homeostasis (P < 0.05). Conversely, miR-31 inhibition demonstrated opposing effects: elevated cortical granule misdistribution rate (P < 0.05); Significant activation of MAPK8/JNK pathway activity (P < 0.01). In conclusion, this study demonstrates that miR-31 coordinates cumulus cell expansion with oocyte metabolic reprogramming by targeting MAPK8, thereby enhancing nuclear-cytoplasmic maturation synchrony.

This study demonstrates that cumulus cell-derived miR-31 promotes the in vitro maturation of porcine oocytes through targeting MAPK8. These results identify miR-31 as a novel regulatory target for enhancing oocyte quality in porcine reproductive technologies.

## Linked entities

- **Genes:** MIR31 (microRNA 31) [NCBI Gene 407035], MAPK8 (mitogen-activated protein kinase 8) [NCBI Gene 5599], PTGS2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 5743], PTX3 (pentraxin 3) [NCBI Gene 5806]

## Full-text entities

- **Genes:** GPX4 (glutathione peroxidase 4) [NCBI Gene 286809] {aka PHGPx}, PTX3 (pentraxin 3) [NCBI Gene 541148], CYP11A1 (cytochrome P450 family 11 subfamily A member 1) [NCBI Gene 338048] {aka CYP11A, CYPXIA1, P450(scc), P450scc}, PTX3 (pentraxin 3) [NCBI Gene 5806] {aka TNFAIP5, TSG-14}, MIR31 (microRNA 31) [NCBI Gene 407035] {aka MIRN31, hsa-mir-31, miR-31}, CDKN1A (cyclin dependent kinase inhibitor 1A) [NCBI Gene 513497] {aka CIP1, SDI1, WAF1, p21}, CDK1 (cyclin dependent kinase 1) [NCBI Gene 983] {aka CDC2, CDC28A, P34CDC2}, BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 280730], HSD3B1 (hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1) [NCBI Gene 281824] {aka HSD3B}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 281181] {aka GAPD}, MIR361 (microRNA mir-361) [NCBI Gene 791044] {aka MIRN361, bta-mir-361, mir-361}, PTGS2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 5743] {aka COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2}, MSLN (mesothelin) [NCBI Gene 10232] {aka MPF, SMRP}, PTGS2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 282023], CCNB1 (cyclin B1) [NCBI Gene 891] {aka CCNB}, FSHR (follicle stimulating hormone receptor) [NCBI Gene 281172], SMAD4 (SMAD family member 4) [NCBI Gene 540248], CASP3 (caspase 3) [NCBI Gene 408016], ACSL4 (acyl-CoA synthetase long chain family member 4) [NCBI Gene 536628] {aka FACL4}, BMP15 (bone morphogenetic protein 15) [NCBI Gene 9210] {aka GDF9B, ODG2, POF4}, CDC42 (cell division cycle 42) [NCBI Gene 532712], SOD1 (superoxide dismutase 1) [NCBI Gene 281495] {aka SOD1L1}, GDF9 (growth differentiation factor 9) [NCBI Gene 2661] {aka POF14}, MIR149 (microRNA mir-149) [NCBI Gene 102465117] {aka bta-mir-149, mir-149}, ESR1 (estrogen receptor 1) [NCBI Gene 407238], SMAD2 (SMAD family member 2) [NCBI Gene 516010], MIR302D (microRNA mir-302d) [NCBI Gene 100313453] {aka bta-mir-302d}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 281572] {aka VEGF, VEGF-A, VPF, eVEGF120, eVEGF164}, PLIN2 (perilipin 2) [NCBI Gene 280981] {aka ADFP}, MIR31 (microRNA mir-31) [NCBI Gene 791002] {aka MIRN31, bta-mir-31, mir-31}, HAS2 (hyaluronan synthase 2) [NCBI Gene 281220], ALB (albumin) [NCBI Gene 280717], MAPK8 (mitogen-activated protein kinase 8) [NCBI Gene 539941] {aka JNK1}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 281020], MAPK8 (mitogen-activated protein kinase 8) [NCBI Gene 5599] {aka JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8}, RIPK1 (receptor interacting serine/threonine kinase 1) [NCBI Gene 8737] {aka AIEFL, IMD57, RIP, RIP-1, RIP1}, RIPK1 (receptor interacting serine/threonine kinase 1) [NCBI Gene 504727], LOC112779322 (galactose-binding lectin-like) [NCBI Gene 112779322] {aka SGL-2}, ACSL4 (acyl-CoA synthetase long chain family member 4) [NCBI Gene 2182] {aka ACS4, FACL4, LACS4, MRX63, MRX68, XLID63}
- **Diseases:** oocyte dysfunction (OMIM:616780), inflammation (MESH:D007249), NC (MESH:C536209), COCs (OMIM:615774), IVF (MESH:C566179)
- **Chemicals:** sodium lactate (MESH:D019354), DCFH-DA (MESH:C029569), water (MESH:D014867), hyaluronic acid (MESH:D006820), cholesterol (MESH:D002784), sodium dodecyl sulfate (MESH:D012967), progesterone (MESH:D011374), oligonucleotides (MESH:D009841), CaCl2 (MESH:D002122), DEPC (MESH:D004047), NaCl (MESH:D012965), FAM (MESH:C031179), polyacrylamide (MESH:C016679), streptomycin (MESH:D013307), lipid peroxides (MESH:D008054), Triton X-100 (MESH:D017830), mineral oil (MESH:D008899), paraformaldehyde (MESH:C003043), Lipid (MESH:D008055), L-cys (MESH:D003545), SYBR Green (MESH:C098022), CO2 (MESH:D002245), GSH (MESH:D005978), ATP (MESH:D000255), ROS (MESH:D017382), glucose (MESH:D005947), polyvinylidene difluoride (MESH:C024865), PBS (MESH:D007854), KCl (MESH:D011189), penicillin (MESH:D010406), caffeine (MESH:D002110), BODIPY 493/503 (MESH:C527198), polyunsaturated fatty acid (MESH:D005231), JC-1 (MESH:C068624), ER Tracker Red (-), 2-ME (MESH:D008623), PVA (MESH:D011142)
- **Species:** Sus scrofa (pig, species) [taxon 9823], Mus musculus (house mouse, species) [taxon 10090], Bos taurus (bovine, species) [taxon 9913], Gallus gallus (bantam, species) [taxon 9031], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** serine/threonine, C1071S, P0018M
- **Cell lines:** 293 T — Homo sapiens (Human), Transformed cell line (CVCL_0063)

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12975322/full.md

---
Source: https://tomesphere.com/paper/PMC12975322